HEADER ISOMERASE 11-APR-23 8SG2 TITLE BIVALENT INTERACTIONS OF PIN1 WITH THE C-TERMINAL TAIL OF PKC COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PIN1,PPIASE PIN1, COMPND 5 ROTAMASE PIN1; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PROTEIN KINASE C BETA TYPE; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: C-TERMINAL RESIDUES 639-661; COMPND 12 SYNONYM: PKC-B,PKC-BETA; COMPND 13 EC: 2.7.11.13; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_CELL: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET SUMO; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606 KEYWDS BIVALENT COMPLEX, PIN1, PROTEIN KINASE C, HYDROPHOBIC MOTIF, TURN KEYWDS 2 MOTIF, ISOMERASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.DIXIT,Y.YANG,X.R.CHEN,T.I.IGUMENOVA REVDAT 2 15-MAY-24 8SG2 1 JRNL REVDAT 1 08-MAY-24 8SG2 0 JRNL AUTH X.R.CHEN,K.DIXIT,Y.YANG,M.I.MCDERMOTT,H.T.IMAM, JRNL AUTH 2 V.A.BANKAITIS,T.I.IGUMENOVA JRNL TITL A NOVEL BIVALENT INTERACTION MODE UNDERLIES A NON-CATALYTIC JRNL TITL 2 MECHANISM FOR PIN1-MEDIATED PROTEIN KINASE C REGULATION. JRNL REF ELIFE V. 13 2024 JRNL REFN ESSN 2050-084X JRNL PMID 38687676 JRNL DOI 10.7554/ELIFE.92884 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH, CYANA REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE (X-PLOR REMARK 3 NIH), GUNTERT, MUMENTHALER, AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: STRUCTURE DETERMINATION REMARK 4 REMARK 4 8SG2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-APR-23. REMARK 100 THE DEPOSITION ID IS D_1000273666. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298 REMARK 210 PH : 6.66; 6.66 REMARK 210 IONIC STRENGTH : 0.1; 0.1 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 1.05 MM [U-13C; U-15N] PEPTIDYL REMARK 210 -PROLYL CIS-TRANS ISOMERASE NIMA- REMARK 210 INTERACTING 1, 0.9 MM THE C- REMARK 210 TERMINAL TAIL OF PKC, 10 MM [U- REMARK 210 100% 2H] IMIDAZOLE, 100 MM REMARK 210 POTASSIUM CHLORIDE, 1 MM TCEP, REMARK 210 0.02 % W/V SODIUM AZIDE, 92% H2O/ REMARK 210 8% D2O; 1.05 MM [U-13C; U-15N] REMARK 210 PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 0.9 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 100% D2O; 1 MM [U-13C; U-15N] REMARK 210 PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 1.3 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O; 0.8 MM [U-13C; U- REMARK 210 15N] PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 5.5 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O; 0.5 MM [U-13C; U- REMARK 210 15N] PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 1.8 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O; 0.5 MM [U-13C; U- REMARK 210 15N] PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 2.5 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O; 1 MM [U-13C; U- REMARK 210 15N] PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 1.5 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O; 1.3 MM [U-13C; U- REMARK 210 15N] PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, 1 REMARK 210 MM THE C-TERMINAL TAIL OF PKC, REMARK 210 10 MM [U-100% 2H] IMIDAZOLE, 100 REMARK 210 MM POTASSIUM CHLORIDE, 1 MM TCEP, REMARK 210 0.02 % W/V SODIUM AZIDE, 92% REMARK 210 H2O/8% D2O; 0.8 MM [U-13C; U-15N] REMARK 210 PEPTIDYL-PROLYL CIS-TRANS REMARK 210 ISOMERASE NIMA-INTERACTING 1, REMARK 210 1.3 MM THE C-TERMINAL TAIL OF REMARK 210 PKC, 10 MM [U-100% 2H] IMIDAZOLE, REMARK 210 100 MM POTASSIUM CHLORIDE, 1 MM REMARK 210 TCEP, 0.02 % W/V SODIUM AZIDE, REMARK 210 92% H2O/8% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D [15N,1H] HSQC; 2D 1H-15N HSQC REMARK 210 NH2; 3D HNCO; 3D HNCACB; 3D C(CO) REMARK 210 NH; 3D CBCA(CO)NH; 3D HNCACO; 3D REMARK 210 HNHA; 3D HNHB; 3D H(CCO)NH; 3D REMARK 210 15N-EDITED NOESY- HSQC; 3D [F1] REMARK 210 13C,15N-FILTERED NOESY-15N-HSQC; REMARK 210 3D [F1] 13C,15N-FILTERED NOESY- REMARK 210 13C-HSQC; 3D 13C-EDITED NOESY- REMARK 210 HSQC; 3D 13CARO-EDITED NOESY- REMARK 210 HSQC; 2D CT [13C, 1H] HSQC; 2D REMARK 210 CT 1H-13C AROMATIC HSQC; 3D HCCH- REMARK 210 TOCSY; 3D HCCH-COSY; 2D (HB) REMARK 210 CB(CGCDCE)HE; 2D (HB)CB(CGCD)HD; REMARK 210 2D [F1] 13C, 15N- FILTERED NOESY; REMARK 210 2D [F2] 13C,15N- FILTERED NOESY; REMARK 210 2D [F1,F2] 13C,15N-FILTERED REMARK 210 NOESY; 2D [F1,F2] 13C,15N- REMARK 210 FILTERED TOCSY; 3D [F1] 13C, 15N- REMARK 210 FILTERED NOESY- 13CARO-HSQC; 2D REMARK 210 [F1] 13C,15N- FILTERED NOESY; 3D REMARK 210 [F1] 13C, 15N-FILTERED NOESY- REMARK 210 13CALI-HSQC; 2D [F2] 13C, 15N- REMARK 210 FILTERED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CCPNMR ANALYSIS, NMRDRAW, REMARK 210 NMRPIPE REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 30 30.68 78.91 REMARK 500 1 PRO A 52 39.39 -63.41 REMARK 500 1 GLN A 66 42.70 -81.52 REMARK 500 1 ILE A 78 105.29 -49.47 REMARK 500 1 LEU B 640 -48.28 -131.91 REMARK 500 1 TPO B 641 -62.75 99.56 REMARK 500 1 ILE B 651 -166.39 -172.47 REMARK 500 1 ASP B 652 66.35 -68.83 REMARK 500 1 SER B 654 -64.99 67.51 REMARK 500 1 GLU B 655 34.20 -74.67 REMARK 500 1 SEP B 660 -63.17 68.89 REMARK 500 2 ALA A 2 -165.91 -105.47 REMARK 500 2 ARG A 17 92.61 -49.52 REMARK 500 2 SER A 42 152.12 68.60 REMARK 500 2 ARG A 74 -60.09 -94.14 REMARK 500 2 ILE A 78 101.24 -49.90 REMARK 500 2 LEU B 640 -59.04 -167.01 REMARK 500 2 TPO B 641 -61.68 93.42 REMARK 500 2 PRO B 643 97.71 -63.60 REMARK 500 2 GLU B 646 -51.93 73.94 REMARK 500 2 VAL B 647 34.19 -84.66 REMARK 500 2 ILE B 648 22.14 -78.32 REMARK 500 2 ASN B 650 -160.79 -129.44 REMARK 500 2 ASP B 652 -62.60 69.96 REMARK 500 2 GLN B 653 57.55 78.76 REMARK 500 2 SEP B 660 -72.26 66.04 REMARK 500 3 ASN A 30 60.73 61.93 REMARK 500 3 PRO A 52 37.94 -71.09 REMARK 500 3 GLN A 66 31.74 -89.45 REMARK 500 3 ILE A 78 106.05 -52.22 REMARK 500 3 SER A 115 0.56 -68.85 REMARK 500 3 SER A 147 -86.98 -84.00 REMARK 500 3 LEU B 640 -38.96 -149.73 REMARK 500 3 TPO B 641 -60.22 98.60 REMARK 500 3 ARG B 649 25.99 -141.77 REMARK 500 3 ILE B 651 -155.49 -172.78 REMARK 500 3 ASP B 652 56.71 -69.50 REMARK 500 3 SER B 654 -68.04 66.43 REMARK 500 3 SEP B 660 -58.63 69.69 REMARK 500 4 SER A 18 15.19 59.80 REMARK 500 4 ASN A 30 61.54 63.68 REMARK 500 4 PRO A 52 36.15 -73.57 REMARK 500 4 GLN A 66 35.19 -83.76 REMARK 500 4 ILE A 78 101.81 -58.43 REMARK 500 4 TPO B 641 -63.74 96.56 REMARK 500 4 ARG B 649 14.58 -152.40 REMARK 500 4 ILE B 651 -167.73 -171.22 REMARK 500 4 ASP B 652 73.71 -66.66 REMARK 500 4 SER B 654 -62.92 68.30 REMARK 500 4 GLU B 655 28.49 -74.50 REMARK 500 REMARK 500 THIS ENTRY HAS 233 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30764 RELATED DB: BMRB REMARK 900 BIVALENT INTERACTIONS OF PIN1 WITH THE C-TERMINAL TAIL OF PKC REMARK 900 RELATED ID: 31080 RELATED DB: BMRB REMARK 900 BIVALENT INTERACTIONS OF PIN1 WITH THE C-TERMINAL TAIL OF PKC DBREF 8SG2 A 1 163 UNP Q13526 PIN1_HUMAN 1 163 DBREF 8SG2 B 639 661 UNP P05771 KPCB_HUMAN 639 661 SEQADV 8SG2 ACE B 638 UNP P05771 ACETYLATION SEQADV 8SG2 NH2 B 662 UNP P05771 AMIDATION SEQRES 1 A 163 MET ALA ASP GLU GLU LYS LEU PRO PRO GLY TRP GLU LYS SEQRES 2 A 163 ARG MET SER ARG SER SER GLY ARG VAL TYR TYR PHE ASN SEQRES 3 A 163 HIS ILE THR ASN ALA SER GLN TRP GLU ARG PRO SER GLY SEQRES 4 A 163 ASN SER SER SER GLY GLY LYS ASN GLY GLN GLY GLU PRO SEQRES 5 A 163 ALA ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER SEQRES 6 A 163 GLN SER ARG ARG PRO SER SER TRP ARG GLN GLU LYS ILE SEQRES 7 A 163 THR ARG THR LYS GLU GLU ALA LEU GLU LEU ILE ASN GLY SEQRES 8 A 163 TYR ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SEQRES 9 A 163 SER LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS SEQRES 10 A 163 ALA ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET SEQRES 11 A 163 GLN LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR SEQRES 12 A 163 GLY GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE SEQRES 13 A 163 HIS ILE ILE LEU ARG THR GLU SEQRES 1 B 25 ACE VAL LEU TPO PRO PRO ASP GLN GLU VAL ILE ARG ASN SEQRES 2 B 25 ILE ASP GLN SER GLU PHE GLU GLY PHE SEP PHE NH2 MODRES 8SG2 TPO B 641 THR MODIFIED RESIDUE MODRES 8SG2 SEP B 660 SER MODIFIED RESIDUE HET ACE B 638 6 HET TPO B 641 17 HET SEP B 660 14 HET NH2 B 662 3 HETNAM ACE ACETYL GROUP HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM NH2 AMINO GROUP HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 ACE C2 H4 O FORMUL 2 TPO C4 H10 N O6 P FORMUL 2 SEP C3 H8 N O6 P FORMUL 2 NH2 H2 N HELIX 1 AA1 THR A 81 SER A 98 1 18 HELIX 2 AA2 ASP A 102 SER A 111 1 10 HELIX 3 AA3 CYS A 113 LYS A 117 5 5 HELIX 4 AA4 GLN A 131 PHE A 139 1 9 SHEET 1 AA1 3 TRP A 11 MET A 15 0 SHEET 2 AA1 3 VAL A 22 ASN A 26 -1 O PHE A 25 N GLU A 12 SHEET 3 AA1 3 ALA A 31 GLN A 33 -1 O ALA A 31 N ASN A 26 SHEET 1 AA2 4 ASP A 121 SER A 126 0 SHEET 2 AA2 4 ARG A 54 VAL A 62 -1 N CYS A 57 O LEU A 122 SHEET 3 AA2 4 ILE A 156 GLU A 163 -1 O GLU A 163 N ARG A 56 SHEET 4 AA2 4 MET A 146 PHE A 151 -1 N VAL A 150 O HIS A 157 LINK C ACE B 638 N VAL B 639 1555 1555 1.34 LINK C LEU B 640 N TPO B 641 1555 1555 1.36 LINK C TPO B 641 N PRO B 642 1555 1555 1.37 LINK C PHE B 659 N SEP B 660 1555 1555 1.34 LINK C SEP B 660 N PHE B 661 1555 1555 1.32 LINK C PHE B 661 N NH2 B 662 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1